|
|
||||||||



*
Gwen Knapp Center for Lupus and Immunology Research, Committee on Immunology and Department of Pathology, and
Ben May Institute for Cancer Research, University of Chicago, Chicago, IL 60637; and
Cancer Biology Program, Hematology/Oncology Division, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215
To study the potential functions of human CD1d (hCD1d), we
developed transgenic (Tg) mice that ectopically express hCD1d under the
control of H-2Kb promoter. High levels of hCD1d expression
were detected in all Tg tissues tested. Skin grafts from the
Kb/hCD1d Tg mice were rapidly rejected by MHC-matched
non-Tg recipient mice, suggesting that hCD1d can act as transplantation
Ags. Furthermore, we were able to elicit hCD1d-restricted
CD8+ CTLs from mice immunized with Kb/hCD1d Tg
splenocytes. These CTLs express TCR rearrangements that are distinct
from invariant TCR of NK T cells, and secrete significant amounts of
IFN-
upon Ag stimulation. Analysis with various hCD1d-expressing
targets and use of Ag presentation inhibitors indicated the recognition
of hCD1d by CTLs did not involve species or tissue-specific ligands nor
require the processing pathways of endosomes or proteasomes.
Additionally, the reactivity of hCD1d-specific CTLs was not affected by
acid stripping followed by brefeldin A treatment, suggesting that CTLs
may recognize a ligand/hCD1d complex that is resistant to acid
denaturation, or empty hCD1d molecules. Our results show that hCD1d can
function as an alloantigen for CD8+ CTLs. The hCD1d Tg mice
provide a versatile model for the study of hCD1d-restricted cytolytic
responses to microbial Ags.
This article has been cited by other articles:
![]() |
A. Toyofuku, Y. Yasunami, K. Nabeyama, M. Nakano, M. Satoh, N. Matsuoka, J. Ono, T. Nakayama, M. Taniguchi, M. Tanaka, et al. Natural Killer T-Cells Participate in Rejection of Islet Allografts in the Liver of Mice Diabetes, January 1, 2006; 55(1): 34 - 39. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Lipscomb and B. J. Masten Dendritic Cells: Immune Regulators in Health and Disease Physiol Rev, January 1, 2002; 82(1): 97 - 130. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |